Most just lately, it's been identified that conolidine and the above derivatives act about the atypical chemokine receptor three (ACKR3. Expressed in similar parts as classical opioid receptors, it binds to some wide array of endogenous opioids. Not like most opioid receptors, this receptor functions as being a scavenger and isn't going to activate